A. Ricobaraza

发表

Functional ultrasound imaging of intrinsic connectivity in the living rat brain with high spatiotemporal resolution

Mickael Tanter, Zsolt Lenkei, Sophie Pezet, 2014, Nature Communications.

Adenovirus-Mediated Inducible Expression of a PD-L1 Blocking Antibody in Combination with Macrophage Depletion Improves Survival in a Mouse Model of Peritoneal Carcinomatosis

M. Buñuales, S. Hervás-Stubbs, S. Lumbreras, 2021, International journal of molecular sciences.

Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation

M. Valencia, J. Artieda, M. Buñuales, 2019, Scientific Reports.

Chronic mild stress in mice promotes cognitive impairment and CDK5-dependent tau hyperphosphorylation

M. Cuadrado-Tejedor, A. García-Osta, A. Ricobaraza, 2011, Behavioural Brain Research.

Understanding the Potential Role of Sirtuin 2 on Aging: Consequences of SIRT2.3 Overexpression in Senescence

E. Puerta, A. Ricobaraza, M. Aymerich, 2021, International journal of molecular sciences.

Gene supplementation of CYP27A1 in the liver restores bile acid metabolism in a mouse model of cerebrotendinous xanthomatosis

M. Avila, M. Ávila, G. González-Aseguinolaza, 2021, Molecular therapy. Methods & clinical development.

Highly efficient generation of glutamatergic/cholinergic NT2-derived postmitotic human neurons by short-term treatment with the nucleoside analogue cytosine β-D-arabinofuranoside.

G. García del Caño, X. Aretxabala, I. González-Burguera, 2016, Stem cell research.

Challenges in the development of heteromer-GPCR-based drugs.

E. Martínez-Pinilla, A. Ricobaraza, P. McCormick, 2013, Progress in molecular biology and translational science.

Exogenous NaV1.1 activity in excitatory and inhibitory neurons reverts Dravet syndrome comorbidities when delivered post-symptom onset in mice with Dravet

Ethan M. Goldberg, M. Rubinstein, E. Kremer, 2022, bioRxiv.

Danio Rerio as Model Organism for Adenoviral Vector Evaluation

G. González-Aseguinolaza, Á. Vales, J. Guerra-Varela, 2019, Genes.

Early sirtuin 2 inhibition prevents age-related cognitive decline in a senescence-accelerated mouse model

Takayoshi Suzuki, E. Puerta, A. Ricobaraza, 2019, Neuropsychopharmacology.

High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy

S. Lumbreras, A. Ricobaraza, R. Hernández-Alcoceba, 2020, International journal of molecular sciences.

Phenylbutyrate is a multifaceted drug that exerts neuroprotective effects and reverses the Alzheimer´s disease-like phenotype of a commonly used mouse model.

R. Franco, A. García-Osta, A. Ricobaraza, 2013, Current pharmaceutical design.

Gene Therapy in Combination with Nitrogen Scavenger Pretreatment Corrects Biochemical and Behavioral Abnormalities of Infant Citrullinemia Type 1 Mice

B. Bénichou, G. González-Aseguinolaza, J. Häberle, 2022, International journal of molecular sciences.

Phenylbutyrate Ameliorates Cognitive Deficit and Reduces Tau Pathology in an Alzheimer's Disease Mouse Model

A. García-Osta, A. Ricobaraza, J. Rı́o, 2009, Neuropsychopharmacology.

Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease

I. Pérez-Otaño, A. García-Osta, A. Ricobaraza, 2012, Hippocampus.

Sildenafil restores cognitive function without affecting β‐amyloid burden in a mouse model of Alzheimer's disease

R. Franco, C. García-Barroso, A. García-Osta, 2011, British journal of pharmacology.

Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling

R. Franco, E. Kostenis, M. Waldhoer, 2014, British journal of pharmacology.

Chronic mild stress accelerates the onset and progression of the Alzheimer's disease phenotype in Tg2576 mice.

R. Franco, A. García-Osta, A. Ricobaraza, 2012, Journal of Alzheimer's disease : JAD.

Long-term phenylbutyrate administration prevents memory deficits in Tg2576 mice by decreasing Abeta.

A. García-Osta, A. Ricobaraza, M. Cuadrado‐Tejedor, 2011, Frontiers in bioscience.

Early changes in hippocampal Eph receptors precede the onset of memory decline in mouse models of Alzheimer's disease.

Jesús Avila, J. Ávila, A. Ricobaraza, 2009, Journal of Alzheimer's disease : JAD.

Rosiglitazone Rescues Memory Impairment in Alzheimer's Transgenic Mice: Mechanisms Involving a Reduced Amyloid and Tau Pathology

A. García-Osta, A. Ricobaraza, J. Rı́o, 2010, Neuropsychopharmacology.

CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum

J. Lanciego, R. Franco, Gemma Navarro, 2014, Experimental Neurology.

Tadalafil crosses the blood–brain barrier and reverses cognitive dysfunction in a mouse model of AD

J. Lanciego, R. Franco, J. Oyarzábal, 2013, Neuropharmacology.

Cannabinoid-induced actomyosin contractility shapes neuronal morphology and growth

F. Rico, S. Scheuring, Z. Lenkei, 2014, eLife.

Phenyl Acyl Acids Attenuate the Unfolded Protein Response in Tunicamycin-Treated Neuroblastoma Cells

R. Franco, E. Martínez-Pinilla, A. Ricobaraza, 2013, PloS one.

Transfer of SCN1A to the brain of adolescent mouse model of Dravet syndrome improves epileptic, motor, and behavioral manifestations

M. Valencia, M. Rubinstein, G. González-Aseguinolaza, 2021, Molecular therapy. Nucleic acids.

Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF

J. Jordán, A. García-Osta, E. Puerta, 2010, Neurobiology of Disease.

Defining the mechanism of action of 4-phenylbutyrate to develop a small-molecule-based therapy for Alzheimer's disease.

R. Franco, J. Oyarzábal, A. García-Osta, 2011, Current medicinal chemistry.

GPR40 activation leads to CREB and ERK phosphorylation in primary cultures of neurons from the mouse CNS and in human neuroblastoma cells

R. Franco, E. Martínez-Pinilla, A. Ricobaraza, 2014, Hippocampus.

Polarized cellular patterns of endocannabinoid production and detection shape cannabinoid signaling in neurons

D. Ladarré, Z. Lenkei, A. Ricobaraza, 2015, Front. Cell. Neurosci..

Alterations of the Hippocampal Neurogenic Niche in a Mouse Model of Dravet Syndrome

A. Ricobaraza, R. Hernández-Alcoceba, J. Encinas, 2020, Frontiers in Cell and Developmental Biology.

Viral vector–mediated expression of NaV1.1, after seizure onset, reduces epilepsy in mice with Dravet syndrome

Ethan M. Goldberg, E. Kremer, Bertrand Beucher, 2023, The Journal of clinical investigation.